Othera Pharmaceuticals   Report issue

For profit Phase 2
Founded: Conshohocken PA United States (2002)
Status: Acquired by Colby Pharmaceutical Company (2012)

Organization Overview

First Clinical Trial
2005
NCT00333060
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (3)

ot-551 (3 trials)

ot-730 (1 trial)

timolol (blocadren) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophy (Phase 2)

Cataract (Phase 2)

Epiretinal Membrane (Phase 2)

Geographic Atrophy (Phase 2)

Glaucoma (Phase 2)

Glaucoma, Open-Angle (Phase 2)

Hypertension (Phase 2)

Macular Degeneration (Phase 2)

Ocular Hypertension (Phase 2)

Retinal Perforations (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 3